Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 17-May-24 4:00 PM View:  | Effector Therapeutics, Inc. (EFTR) | 15-May-24 | Grant | 1,806 | $1.68 | $3,039.50 | 5% 33.18K to 34.99K | |
| 16-Nov-23 5:30 PM View: | Effector Therapeutics, Inc. (EFTR) | 15-Nov-23 | Grant | 5,979 | $0.50 | $2,973.36 | < 1% 823.56K to 829.54K | |
| 14-Aug-23 8:00 AM View: | Effector Therapeutics, Inc. (EFTR) | 11-Aug-23 | Option Exercise | 33,799 | $0.52 | $17,575.50 | 4% 789.76K to 823.56K | |
| 16-May-23 8:03 AM View: | Effector Therapeutics, Inc. (EFTR) | 15-May-23 | Grant | 6,401 | $0.46 | $2,938.06 | < 1% 783.36K to 789.76K | |
| 16-Nov-22 6:27 PM View: | Effector Therapeutics, Inc. (EFTR) | 15-Nov-22 | Grant | 6,047 | $0.47 | $2,832.41 | < 1% 777.32K to 783.36K | |
| 09-Jun-22 6:00 AM View: | Effector Therapeutics, Inc. (EFTR) | 07-Jun-22 | Private Purchase | 20,000 | $1.37 | $27,400.00 | 3% 757.32K to 777.32K | |
| 17-May-22 8:44 PM View: | Effector Therapeutics, Inc. (EFTR) | 13-May-22 | Grant | 1,837 | $1.53 | $2,810.61 | < 1% 755.48K to 757.32K | |
| 27-Aug-21 5:54 PM View: | Effector Therapeutics, Inc. (EFTR) | 25-Aug-21 | Grant | 562,339 | $0.89 | $500,000.00 | 100% 562.34K to 1.12M | |
| 27-Aug-21 5:54 PM View: | Effector Therapeutics, Inc. (EFTR) | 25-Aug-21 | Grant | 193,141 | -- | -- | 17% 1.12M to 1.32M | |
| 02-Jun-16 7:09 PM View: | Tracon Pharmaceuticals, Inc. (TCON) | 01-Jun-16 | Grant | 7,500 | -- | -- | 100% 0 to 7.5K | |
| 02-Jun-14 8:10 PM View: | GenMark Diagnostics, Inc. (GNMK) | 29-May-14 | Grant | 5,677 | -- | -- | 38% 14.92K to 20.6K | |
| 23-May-13 7:54 PM View: | GenMark Diagnostics, Inc. (GNMK) | 22-May-13 | Grant | 14,922 | -- | -- | 100% 0 to 14.92K | |
| 30-May-08 8:55 PM View: | Anadys Pharmaceuticals Inc. (ANDS) | 30-May-08 | Option Exercise | 33,898 | $2.95 | $99,999.10 | 14% 247.12K to 281.02K | 30% |
| 04-Sep-07 6:55 PM View: | Anadys Pharmaceuticals Inc. (ANDS) | 04-Sep-07 | Market Purchase | 13,236 | $2.35 | $31,095.60 | 6% 225.87K to 239.11K | 14% |
| 04-Sep-07 6:55 PM View: | Anadys Pharmaceuticals Inc. (ANDS) | 31-Aug-07 | Market Purchase | 12,200 | $2.11 | $25,714.20 | 6% 213.67K to 225.87K | 28% |
| 04-Sep-07 6:55 PM View: | Anadys Pharmaceuticals Inc. (ANDS) | 30-Aug-07 | Market Purchase | 124,564 | $2.00 | $249,128.00 | 140% 89.11K to 213.67K | 34% |
| 16-Jan-07 7:09 PM View: | Anadys Pharmaceuticals Inc. (ANDS) | 12-Jan-07 | Option Exercise | 25,000 | $2.95 | $73,750.00 | 40% 62.26K to 87.26K | |
| 17-Mar-06 7:21 PM View: | Anadys Pharmaceuticals Inc. (ANDS) | 16-Mar-06 | Market Sale (Planned) | 4,000 | $16.00 | $64,000.00 | (6%) 63.67K to 59.67K | 83% |
| 06-Mar-06 9:40 PM View: | Anadys Pharmaceuticals Inc. (ANDS) | 02-Mar-06 | Market Sale | 3,000 | $14.00 | $42,000.00 | (4%) 67.03K to 64.03K | 81% |
| 02-Jun-05 6:28 PM View: | Anadys Pharmaceuticals Inc. (ANDS) | 31-May-05 | Option Exercise | 25,400 | $2.95 | $74,930.00 | 63% 40.3K to 65.7K |